DONGIOVANNI, PAOLA
DONGIOVANNI, PAOLA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study]
2021 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni
A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination
2010 M. Viganò, P. Lampertico, P. Dongiovanni, F. Facchetti, L.V.C. Valenti, R. Soffredini, S.R. Fargion, M. Colombo
A novel alpha1-antitrypsin null variant (PiQ0Milano)
2013 R. Rametta, G. Nebbia, P. Dongiovanni, M. Farallo, S. Fargion, L. Valenti
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
2017 P. Dongiovanni, L. Valenti
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis
2010 A. Auinger, L. Valenti, M. Pfeuffer, U. Helwig, J. Herrmann, A.L. Fracanzani, P. Dongiovanni, S. Fargion, J. Schrezenmeir, D. Rubin
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
2014 L. Valenti, A.L. Fracanzani, P. Dongiovanni, S. Rovida, R. Rametta, E. Fatta, E.A. Pulixi, M. Maggioni, S. Fargion
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype
2011 E. Galmozzi, B. Del Menico, R. Rametta, P. Dongiovanni, A. L. Fracanzani, L. Benedan, V. Borroni, P. Maggioni, S. R. Fargion, L. V. C. Valenti
A1-antitripsin mutations are associated with altered iron metabolism but not liver damage in non alcoholic fatty liver disease
2007 L. Valenti, P. Dongiovanni, A. Piperno, A. L Fracanzani, R. Rametta, P. Trombini, S. Fargion
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
2021 K.J. Kim, J.K. Kang, Y.H. Jung, S.B. Lee, R. Rametta, P. Dongiovanni, L. Valenti, U.B. Pajvani
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 L.V.C. Valenti, R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 L.V.C. Valenti, R. Rametta, M. Ruscica, E. Canavesi, A.L. Fracanzani, P. Dongiovanni, P. Magni, S.R. Fargion
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion, L.V.C. Valenti
Alcohol or gut microbiota : who is the guilty?
2019 M. Meroni, M. Longo, P. Dongiovanni
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease
2010 L. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, M. Maggioni, A.L. Fracanzani, S. Fargion
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease
2010 L.V.C. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, A.L. Fracanzani, S.R. Fargion
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease
2010 E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, P. Maggioni, A.L. Fracanzani, S.R. Fargion, L.V.C. Valenti
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations
2008 L.V.C. Valenti, P. Dongiovanni, A.L. Fracanzani, S.R. Fargion
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al
2008 L. Valenti, P. Dongiovanni, A.L. Fracanzani, S. Fargion
Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?
2009 L.V.C. Valenti, A.L. Fracanzani, P. Dongiovanni, P. Vezzoli, S.R. Fargion
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
2018 P. Dongiovanni, S. Stender, A. Pietrelli, R.M. Mancina, A. Cespiati, S. Petta, S. Pelusi, P. Pingitore, S. Badiali, M. Maggioni, V. Mannisto, S. Grimaudo, R.M. Pipitone, J. Pihlajamaki, A. Craxi, M. Taube, L.M.S. Carlsson, S. Fargion, S. Romeo, J. Kozlitina, L. Valenti